1. Home
  2. Analysis
  3. Ceftriaxone
  4. Decreased-interest

Ceftriaxone and Decreased interest - a phase IV clinical study of FDA data

Summary:

Decreased interest is reported as a side effect among people who take Ceftriaxone (ceftriaxone sodium), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have High blood pressure.

The phase IV clinical study analyzes which people have Decreased interest when taking Ceftriaxone. It is created by eHealthMe based on reports of 40,872 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Decreased interest?

Decreased interest is found to be associated with 917 drugs and 961 conditions by eHealthMe. Check the latest studies of Decreased interest.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

40,872 people reported to have side effects when taking Ceftriaxone.
Among them, 39 people (0.1%) have Decreased interest.

Could Ceftriaxone cause Decreased interest?

Among these 39 people:

How long have people been on Ceftriaxone when they have Decreased interest? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Decreased interest when taking Ceftriaxone? *

  • female: 57.89 %
  • male: 42.11 %

What is the age of people who have Decreased interest when taking Ceftriaxone? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 13.51 %
  • 30-39: 2.7 %
  • 40-49: 5.41 %
  • 50-59: 35.14 %
  • 60+: 43.24 %

What are other drugs people take besides Ceftriaxone? *

  1. Zometa: 26 people, 66.67%
  2. Ambien: 25 people, 64.10%
  3. Vancomycin: 20 people, 51.28%
  4. Aredia: 16 people, 41.03%
  5. Levaquin: 15 people, 38.46%
  6. Amoxicillin: 15 people, 38.46%
  7. Klonopin: 14 people, 35.90%
  8. Percocet: 14 people, 35.90%
  9. Proventil: 13 people, 33.33%
  10. Vicodin: 13 people, 33.33%

What are other side effects people have besides Decreased interest? *

  1. General Physical Health Deterioration (weak health status): 29 people, 74.36%
  2. Pain: 27 people, 69.23%
  3. Anaemia (lack of blood): 27 people, 69.23%
  4. Stress And Anxiety: 26 people, 66.67%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 25 people, 64.10%
  6. Weakness: 25 people, 64.10%
  7. Weight Decreased: 24 people, 61.54%
  8. Osteonecrosis Of Jaw (death of bone of jaw): 23 people, 58.97%
  9. Dyspnea (difficult or laboured breathing): 23 people, 58.97%
  10. Neuropathy Peripheral (surface nerve damage): 22 people, 56.41%

What are the existing conditions these people have? *

  1. High Blood Pressure: 14 people, 35.90%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 15.38%
  3. Multiple Myeloma (cancer of the plasma cells): 6 people, 15.38%
  4. Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 12.82%
  5. Escherichia Bacteraemia (presence of bacteria escherichia coli in the blood): 3 people, 7.69%
  6. Pain: 3 people, 7.69%
  7. Pyogenic Liver Abscess (liver abscess caused by bacteria): 3 people, 7.69%
  8. Depression: 2 people, 5.13%
  9. Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 5.13%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and have Decreased interest?

- Check whether Decreased interest is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone:

Decreased interest treatments and more:

How severe was Decreased interest and when was it recovered:

Expand to all the drugs that have ingredients of ceftriaxone sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Decreased interest:

Browse all the conditions that are associated with Decreased interest:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.